Published in Nature on August 26, 1993
Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc Natl Acad Sci U S A (1996) 2.57
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One (2011) 2.36
Molecular evidence of HIV-1 transmission in a criminal case. Proc Natl Acad Sci U S A (2002) 1.92
The global transmission network of HIV-1. J Infect Dis (2013) 1.68
In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50
HIV phylogenetics. BMJ (2007) 1.07
Molecular investigation of transmission of human immunodeficiency virus type 1 in a criminal case. Clin Diagn Lab Immunol (2001) 0.87
A HIV-1 heterosexual transmission chain in Guangzhou, China: a molecular epidemiological study. Virol J (2009) 0.83
Social and Genetic Networks of HIV-1 Transmission in New York City. PLoS Pathog (2017) 0.77
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol (1990) 6.73
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol (1990) 5.20
Yeast-enhanced green fluorescent protein (yEGFP): a reporter of gene expression in Candida albicans. Microbiology (1997) 5.00
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Molecular evidence for genetic mixing of Arctic and Antarctic subpolar populations of planktonic foraminifers. Nature (2000) 3.58
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A (1996) 3.50
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J (2001) 3.48
Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast (2000) 3.34
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25
Enzyme null alleles in natural populations of Drosophila melanogaster: Frequencies in a North Carolina population. Proc Natl Acad Sci U S A (1980) 3.24
Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol (1994) 3.23
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology (2000) 2.86
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol (1996) 2.68
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Causes of HIV diversity. Nature (1995) 2.48
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun (1997) 2.24
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol (2001) 2.18
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Null allele frequencies at allozyme loci in natural populations of Drosophila melanogaster. Genetics (1981) 2.14
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection. J Virol (2000) 2.11
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10
The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
Case report: foreign body in the palate of an infant. Br Dent J (2008) 2.04
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc Natl Acad Sci U S A (1994) 1.99
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
Insertion-deletion variation at the yellow-achaete-scute region in two natural populations of Drosophila melanogaster. Genet Res (1989) 1.87
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int (2006) 1.84
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol (2007) 1.74
The relationship between mRNA stability and length in Saccharomyces cerevisiae. Nucleic Acids Res (1986) 1.73
Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73
Conservation in rat liver of light and heavy subunit sequences of mammalian ferritin. Presence of unique octopeptide in the light subunit. J Biol Chem (1984) 1.73
A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol (2005) 1.72
The efficiency of folding of some proteins is increased by controlled rates of translation in vivo. A hypothesis. J Mol Biol (1987) 1.72
Criminalisation of HIV transmission: implications for public health in Scotland. BMJ (2001) 1.69
Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68